tirzepatide to wegovy conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Wegovy to Zepbound Conversion Chart:

Medicines and Healthcare products Regulatory Agency (MHRA), 2025

Real-world pharmacovigilance data is broadly consistent with these findings, though isolated case reports exist for both medications

Such a diet promotes the shift from using carbohydrates as the body's primary fuel source to fats via a process called ketosis (Daley et al., 2025)

Studies show that consuming protein and fat 10-15 minutes before carbohydrates at the same meal enhances GLP-1 secretion and improves the overall glycemic response

Prescription bottles, pharmacy printouts, insurance statements, medical bills, appointment records, and even the medication packaging itself

What happens to our relationship with food when hunger is no longer a guide